(a) A statewide drug therapy management protocol developed, in consultation with a physician with a background in addiction medicine, by the Public Health and Pharmacy Formulary Advisory Committee convened under ORS 689.649 and adopted by State Board of Pharmacy rule pursuant to ORS 689.645; or
(b) A collaborative drug therapy management agreement.
(2) A pharmacist may register with the Drug Enforcement Administration of the United States Department of Justice as a mid-level practitioner for the purpose of prescribing, dispensing and administering a controlled substance in Schedule II, III, IV or V that is a medication for the treatment of opioid use disorder.
(3) The board may adopt rules to carry out this section. [2024 c.70 §7; 2025 c.532 §18]